Association between secretor status and respiratory viral illness.

PubWeight™: 1.47‹?› | Rank: Top 5%

🔗 View Article (PMC 1671169)

Published in BMJ on October 05, 1991

Authors

M W Raza1, C C Blackwell, P Molyneaux, V S James, M M Ogilvie, J M Inglis, D M Weir

Author Affiliations

1: Department of Medical Microbiology, University of Edinburgh Medical School.

Articles citing this

Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J Virol (2003) 2.82

Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci U S A (2011) 2.47

Searching for signals of evolutionary selection in 168 genes related to immune function. Hum Genet (2005) 1.97

Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Mol Genet (2007) 1.72

Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota. Proc Natl Acad Sci U S A (2013) 1.69

Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? Lancet Infect Dis (2006) 1.56

Widespread balancing selection and pathogen-driven selection at blood group antigen genes. Genome Res (2008) 1.40

The role of host genetics in susceptibility to influenza: a systematic review. PLoS One (2012) 1.39

Contrasting patterns of polymorphisms at the ABO-secretor gene (FUT2) and plasma alpha(1,3)fucosyltransferase gene (FUT6) in human populations. Genetics (2001) 1.30

Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm. J Proteome Res (2012) 1.23

Human milk glycomics and gut microbial genomics in infant feces show a correlation between human milk oligosaccharides and gut microbiota: a proof-of-concept study. J Proteome Res (2014) 1.12

Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88

Factors enhancing adherence of toxigenic Staphylococcus aureus to epithelial cells and their possible role in sudden infant death syndrome. Epidemiol Infect (1993) 0.85

Secretor status and heterosexual transmission of HIV. BMJ (1991) 0.80

Lewis phenotype, secretor status, and coeliac disease. Gut (1994) 0.79

The H antigen at epithelial surfaces is associated with susceptibility to asthma exacerbation. Am J Respir Crit Care Med (2010) 0.78

Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections. Nat Commun (2017) 0.75

Articles cited by this

ABO Blood Groups and Acute Respiratory Virus Disease. Br Med J (1962) 2.30

Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet (1986) 2.05

Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91

Secretor status, smoking and carriage of Neisseria meningitidis. Epidemiol Infect (1990) 1.55

Streptococci, ABO blood groups, and secretor status. Am J Hum Genet (1969) 1.46

The Stonehouse study: secretor status and carriage of Neisseria species. Epidemiol Infect (1989) 1.28

Possible role of blood-group secretory substances in the aetiology of cholera. Trans R Soc Trop Med Hyg (1978) 1.27

Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet (1986) 1.26

Oral carriage of Candida albicans, ABO blood group and secretor status in healthy subjects. J Med Vet Mycol (1988) 1.20

Secretor state of patients with insulin dependent or non-insulin-dependent diabetes mellitus. Br Med J (Clin Res Ed) (1987) 1.19

Non-secretion of blood group antigens and susceptibility to infection by Candida species. FEMS Microbiol Immunol (1989) 1.13

Lewis a blood group antigen of non-secretors: a receptor for candida blastospores. FEMS Microbiol Immunol (1989) 1.02

Blood group, secretor status and oral carriage of yeasts among patients with diabetes mellitus. Diabetes Res (1989) 1.00

Increased prevalence of non-secretors in patients with Graves' disease: evidence for an infective aetiology? Br Med J (Clin Res Ed) (1988) 0.94

The effect of ABO blood groups on the incidence of epidemic influenza and on the response to live attenuated and detergent split influenza virus vaccines. J Hyg (Lond) (1978) 0.89

Semi-quantitative determination of H type 1 and type 2 antigens on buccal epithelial cells and in saliva of secretors and non-secretors. Vox Sang (1990) 0.89

Secretor state and immunoglobulin levels among women with recurrent urinary tract infections. J Clin Lab Immunol (1987) 0.88

Articles by these authors

Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers. Br Med J (Clin Res Ed) (1986) 9.64

Respiratory viral infection in childhood. A survey in general practice, Roehampton 1967-1972. J Hyg (Lond) (1975) 3.19

Respiratory viral infection and wheezy bronchitis in childhood. Thorax (1979) 3.01

Intranuclear virus particles in human genital wart tissue: observations on the ultrastructure of the epidermal layer. J Ultrastruct Res (1968) 2.38

Human immunodeficiency virus and drug misuse: the Edinburgh experience. Br Med J (Clin Res Ed) (1987) 2.37

Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol (1981) 2.26

Antibodies against the mitochondrial fraction of liver after toxic liver damage in rats. Clin Exp Immunol (1966) 2.24

Allergic alveolitis in a maltworker. Thorax (1968) 2.21

Heterosexual spread of human immunodeficiency virus in Edinburgh. Br Med J (Clin Res Ed) (1988) 2.15

Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet (1986) 2.05

Comparison of atypical rotaviruses from calves, piglets, lambs and man. J Gen Virol (1984) 2.03

Does infection with HIV affect the outcome of pregnancy? Br Med J (Clin Res Ed) (1988) 2.01

An outbreak of meningococcal disease in Stonehouse: planning and execution of a large-scale survey. Epidemiol Infect (1987) 1.95

Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91

Antibodies in human brucellosis. Br Med J (1967) 1.85

Factors influencing the immune response. I. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intravenous injection of bovine serum albumin in rabbits. Clin Exp Immunol (1967) 1.85

Naturally occurring anti-tissue antibodies in rat sera. Clin Exp Immunol (1966) 1.75

Serological studies with human papova (wart) virus. J Hyg (Lond) (1970) 1.69

Helicobacter pylori in the mouth--negative isolation from dental plaque and saliva. Eur J Gastroenterol Hepatol (1996) 1.67

Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. J Gen Virol (1983) 1.58

Prevalence of HIV among childbearing women and women having termination of pregnancy: multidisciplinary steering group study. BMJ (1992) 1.57

Allergic alveolitis in maltworkers. A clinical, mycological, and immunological study. Q J Med (1969) 1.57

Secretor status, smoking and carriage of Neisseria meningitidis. Epidemiol Infect (1990) 1.55

Frequency and some properties of clinical isolates of methicillin-resistant Staphylococcus aureus. Am J Clin Pathol (1975) 1.54

Increased phagocytic cell activity and anaemia in Corynebacterium parvum treated mice. Br J Exp Pathol (1974) 1.53

Immune response to a soluble protein antigen in NZB mice. Nature (1968) 1.51

Factors influencing the immune response. 3. The blocking effect of Corynebacterium parvum upon the induction of acquired immunological unresponsiveness to bovine serum albumin in the adult rabbit. Clin Exp Immunol (1968) 1.46

The treatment of plantar warts in the home. A critical appraisal of a new preparation. Practitioner (1971) 1.42

HTLV-III antibodies in an Edinburgh clinic. Lancet (1986) 1.35

ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. Br Med J (Clin Res Ed) (1982) 1.35

The serology of autologous immune complex nephritis in the rat. Clin Exp Immunol (1969) 1.33

Adjuvant-induced antired blood cell activity in CBA mice. Clin Exp Immunol (1971) 1.31

ABO blood group, secretor status and detection of Helicobacter pylori among patients with gastric or duodenal ulcers. Epidemiol Infect (1991) 1.30

The Stonehouse study: secretor status and carriage of Neisseria species. Epidemiol Infect (1989) 1.28

Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet (1986) 1.26

Mechanisms of macrophage activation. Clin Exp Immunol (1980) 1.25

The characteristics of binding of Corynebacterium parvum to glass-adherent mouse peritoneal exudate cells. Clin Exp Immunol (1976) 1.25

Non-specific recognition mechanisms by mononuclear phagocytes. Clin Exp Immunol (1977) 1.25

Viral infection as a precipitant of wheeze in children. Combined home and hospital study. Arch Dis Child (1978) 1.23

In vitro binding of Helicobacter pylori to human gastric mucin. Infect Immun (1991) 1.20

Spontaneous abortion after hand-foot-and-mouth disease caused by Coxsackie virus A16. Br Med J (1980) 1.20

Secretor state of patients with insulin dependent or non-insulin-dependent diabetes mellitus. Br Med J (Clin Res Ed) (1987) 1.19

Vertical transmission of HIV: a prospective study. Arch Dis Child (1989) 1.18

Toxigenic bacteria and sudden infant death syndrome (SIDS): nasopharyngeal flora during the first year of life. FEMS Immunol Med Microbiol (1999) 1.18

Activation of the classical and alternate pathways of complement by Corynebacterium parvum. Clin Exp Immunol (1975) 1.18

Factors affecting carriage of Neisseria meningitidis among Greek military recruits. Epidemiol Infect (1992) 1.18

The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells. FEMS Immunol Med Microbiol (1999) 1.17

Virological findings and blood gas tensions in acute lower respiratory tract infections in children. Br Med J (1974) 1.17

Severe Chlamydia psittaci sepsis in pregnancy. Q J Med (1985) 1.16

The immunologicial consequences of cell death. Lancet (1967) 1.16

Susceptibility to infection in relation to SIDS. J Clin Pathol (1992) 1.16

Antibiotic sensitivities of Neisseria meningitidis isolates from patients and carriers in Greece. Epidemiol Infect (1992) 1.15

The in vitro killing of syngeneic cells by peritoneal cells from adjuvant-stimulated mice. Cell Immunol (1975) 1.14

Non-secretion of blood group antigens and susceptibility to infection by Candida species. FEMS Microbiol Immunol (1989) 1.13

Detection of respiratory syncytial virus in acute bronchiolitis in infants. J Med Virol (1992) 1.12

Subclinical chronic Q fever. Q J Med (1985) 1.11

Rapid diagnosis of herpes simplex virus infections in conventional and shell vial cell cultures using monoclonal antibodies. J Virol Methods (1987) 1.08

Chemotaxis of polymorphs induced by tissue antigens and normal serum in rats: a possible clearance mechanism. Clin Exp Immunol (1967) 1.07

Antitissue antibodies and immunological tolerance to self. Arthritis Rheum (1969) 1.07

Failure to induce tolerance to rat tissue antigens. Immunology (1967) 1.07

A study of infective and other factors in exacerbations of chronic bronchitis. Br J Dis Chest (1980) 1.07

Inhibition of bacterial binding to mouse macrophages by Pseudomonas alginate. J Clin Lab Immunol (1983) 1.06

Use of PCR in resolving diagnostic difficulties potentially caused by genetic variation of hepatitis B virus. J Clin Pathol (1998) 1.05

Factors influencing the immune response. II. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intraperitoneal injection of bovine serum albumin in rabbits. Clin Exp Immunol (1967) 1.05

In vitro evaluation of the new oral cephalosporin cefatrizine: comparison with other cephalosporins. Antimicrob Agents Chemother (1976) 1.04

Chronic atrophic oral candidiasis among patients with diabetes mellitus--role of secretor status. Epidemiol Infect (1991) 1.03

Presence of bacterial binding 'lectin-like' receptors on phagocytes. Immunology (1981) 1.03

The role of bacterial toxins in sudden infant death syndrome (SIDS). Int J Med Microbiol (2002) 1.02

Macrophage migration inhibition induced by tissue antigen in guinea-pigs. Clin Exp Immunol (1971) 1.02

Lewis a blood group antigen of non-secretors: a receptor for candida blastospores. FEMS Microbiol Immunol (1989) 1.02

A study of respiratory infections in the elderly to assess the role of respiratory syncytial virus. J Infect (1983) 1.01

The immune response after tissue injury. Pathol Eur (1966) 1.01

The effect of prone posture on nasal temperature in children in relation to induction of staphylococcal toxins implicated in sudden infant death syndrome. FEMS Immunol Med Microbiol (1999) 1.01

Personality and medical perception in benign myalgic encephalomyelitis. Lancet (1980) 1.01

Blood group, secretor status and oral carriage of yeasts among patients with diabetes mellitus. Diabetes Res (1989) 1.00

The in vitro activity of peritoneal exudate cells from New Zealand black mice (NZB/B1) in the presence of I-125-BSA (bovine serum albumin). Clin Exp Immunol (1972) 1.00

In vitro studies on the heterogeneity of equine antibodies to human lymphoid tissue. Immunochemistry (1969) 1.00

Development of anti-tissue antibodies in rats. Clin Exp Immunol (1969) 1.00

Heat labile antibody in rat serum. Clin Exp Immunol (1968) 0.99

Binding of bacteria to HEp-2 cells infected with influenza A virus. FEMS Immunol Med Microbiol (1999) 0.98

Amoxycillin: pilot study of its use in pneumonia and chronic bronchitis. Br J Clin Pract (1973) 0.98